MVIS vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

MVIS

42.9
AI Score
VS
CLOV Wins

CLOV

45.8
AI Score

Investment Advisor Scores

MVIS

43score
Recommendation
HOLD

CLOV

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MVIS CLOV Winner
Revenue 4.81M 2.25B CLOV
Net Income -74.47M 61.77M CLOV
Net Margin -1548.8% 2.7% CLOV
Operating Income -69.04M 61.77M CLOV
ROE -327.4% 15.8% CLOV
ROA -82.0% 8.2% CLOV
Total Assets 90.83M 753.68M CLOV
Current Ratio 0.80 1.55 CLOV
Free Cash Flow -51.04M 201.03M CLOV

Relative Price Performance (Last 90 Days)

MVIS 1M: -6.0% · 3M: -50.8% CLOV 1M: +3.4% · 3M: +7.7%

Current Technical Phase

MVIS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -25.4%), weak momentum, RSI 39

RSI (14): 38.5 · Price: $1.10

CLOV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.9% over 20 days), RSI 59

RSI (14): 59.2 · Price: $4.96

Fundamentals Snapshot

Metric MVIS CLOV
Market Cap — —
Forward P/E -6.7 27.6
Trailing P/E — 493.0
Revenue (TTM) — —
Revenue Growth 9.0% 0.5%
Gross Margin -2.8% 0.2%
Operating Margin -8.9% 0.0%
EPS -5.13 0.01
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLOV is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.